Clinical features and risk factors of adverse clinical outcomes in central pulmonary embolism using machine learning analysis
Omar Cantú-Martínez(Jefferson Einstein Philadelphia Hospital), Glenn Eiger(Thomas Jefferson University), Kevin Bryan Lo(Einstein Medical Center Philadelphia), Ammaar Wattoo(Thomas Jefferson University), Brenda Chiang(Jefferson Einstein Philadelphia Hospital), Simone A. Jarrett(Jefferson Einstein Philadelphia Hospital), Sahana Tito(Jefferson Einstein Philadelphia Hospital), Alexander Prendergast(Jefferson Einstein Philadelphia Hospital), Jose Manuel Martinez Manzano(Brigham and Women's Hospital), Zurab Azmaiparashvili(Jefferson Hospital), Sadia Benzaquen(Jefferson Einstein Philadelphia Hospital)
Cited by 7
Related Papers
Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association
|Circulation|2023|1.7k
A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association
|Circulation|2023|1.1k
Interstitial Lung Disease in Relatives of Patients with Pulmonary Fibrosis
|American Journal of Respiratory and Critical Care Medicine|2020|105
Utility of a Molecular Classifier as a Complement to High-Resolution Computed Tomography to Identify Usual Interstitial Pneumonia
|American Journal of Respiratory and Critical Care Medicine|2020|82
Single Cell RNA-seq and Mass Cytometry Reveals a Novel and a Targetable Population of Macrophages in Idiopathic Pulmonary Fibrosis
|bioRxiv (Cold Spring Harbor Laboratory)|2021|48